FDA Gives Third COVID-19 Antibody Drug Emergency Use Approval

FDA Gives Third COVID-19 Antibody Drug Emergency Use Approval

Another COVID-19 antibody-drug has been given emergency use approval by the U.S. Food and Drug Administration. The said drug was developed by GlaxoSmithKline and Vir Biotechnology.
Convalescent plasma from a recovered coronavirus disease (COVID-19) patient at Bloodworks Northwest

FDA Puts Emergency Approval for Blood Plasma as COVID-19 Treatment on Hold

By Dana Cruz
The U.S. Food and Drug Administration (FDA) put the emergency use authorization for blood plasma as a COVID-19 Treatment on hold, reported The New York Times.
Most Read
  1. Maite Perroni's Relationship with Anahí & Dulce María Is Seemingly Strained
  2. Ángela Aguilar Booed at the Kids Choice Awards
Real Time Analytics